UBS Group’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-221,597
| Closed | -$4.18M | – | 8779 |
|
|
2019
Q3 | $4.18M | Buy |
221,597
+171,442
| +342% | +$1.96M | ﹤0.01% | 2561 |
|
|
2019
Q2 | $591K | Sell |
50,155
-71,682
| -59% | -$868K | ﹤0.01% | 4171 |
|
|
2019
Q1 | $1.66M | Buy |
121,837
+20,005
| +20% | +$259K | ﹤0.01% | 3150 |
|
|
2018
Q4 | $1.04M | Buy |
101,832
+81,456
| +400% | +$1.04M | ﹤0.01% | 3647 |
|
|
2018
Q3 | $339K | Buy |
20,376
+17,288
| +560% | +$312K | ﹤0.01% | 4676 |
|
|
2018
Q2 | $49K | Sell |
3,088
-225,749
| -99% | -$3.43M | ﹤0.01% | 5981 |
|
|
2018
Q1 | $2.91M | Buy |
228,837
+212,303
| +1,284% | +$3.07M | ﹤0.01% | 2792 |
|
|
2017
Q4 | $189K | Sell |
16,534
-60,476
| -79% | -$675K | ﹤0.01% | 4946 |
|
|
2017
Q3 | $943K | Buy |
77,010
+76,003
| +7,547% | +$792K | ﹤0.01% | 3762 |
|
|
2017
Q2 | $12K | Sell |
1,007
-610
| -38% | -$11.3K | ﹤0.01% | 6676 |
|
|
2017
Q1 | $33K | Sell |
1,617
-35,696
| -96% | -$790K | ﹤0.01% | 5799 |
|
|
2016
Q4 | $776K | Buy |
37,313
+36,459
| +4,269% | +$948K | ﹤0.01% | 3765 |
|
|
2016
Q3 | $28K | Sell |
854
-782
| -48% | -$23.8K | ﹤0.01% | 6014 |
|
|
2016
Q2 | $41K | Sell |
1,636
-9,493
| -85% | -$257K | ﹤0.01% | 5676 |
|
|
2016
Q1 | $272K | Sell |
11,129
-12,803
| -53% | -$296K | ﹤0.01% | 4272 |
|
|
2015
Q4 | $791K | Sell |
23,932
-91,249
| -79% | -$3.09M | ﹤0.01% | 3587 |
|
|
2015
Q3 | $3.77M | Sell |
115,181
-20,422
| -15% | -$868K | ﹤0.01% | 2167 |
|
|
2015
Q2 | $7.18M | Buy |
+135,603
| New | +$4.93M | ﹤0.01% | 1750 |
|